Literature DB >> 23868178

Distinct patterns of DNA methylation in conventional adenomas involving the right and left colon.

Devin C Koestler1, Jing Li1, John A Baron1, Gregory J Tsongalis2, Lynn F Butterly3, Martha Goodrich1, Corina Lesseur1, Margaret R Karagas1, Carmen J Marsit4, Jason H Moore5, Angeline S Andrew1, Amitabh Srivastava6.   

Abstract

Recent studies have shown two distinct non-CIMP methylation clusters in colorectal cancer, raising the possibility that DNA methylation, involving non-CIMP genes, may play a role in the conventional adenoma-carcinoma pathway. A total of 135 adenomas (65 left colon and 70 right colon) were profiled for epigenome-wide DNA methylation using the Illumina HumanMethylation450 BeadChip. A principal components analysis was performed to examine the association between variability in DNA methylation and adenoma location. Linear regression and linear mixed effects models were used to identify locus-specific differential DNA methylation in adenomas of right and left colon. A significant association was present between the first principal component and adenoma location (P=0.007), even after adjustment for subject age and gender (P=0.009). A total of 168 CpG sites were differentially methylated between right- and left-colon adenomas and these loci demonstrated enrichment of homeobox genes (P=3.0 × 10(-12)). None of the 168 probes were associated with CIMP genes. Among CpG loci with the largest difference in methylation between right- and left-colon adenomas, probes associated with PRAC (prostate cancer susceptibility candidate) gene showed hypermethylation in right-colon adenomas whereas those associated with CDX2 (caudal type homeobox transcription factor 2) showed hypermethylation in left-colon adenomas. A subgroup of left-colon adenomas enriched for current smokers (OR=6.1, P=0.004) exhibited a methylation profile similar to right-colon adenomas. In summary, our results indicate distinct patterns of DNA methylation, independent of CIMP genes, in adenomas of the right and left colon.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23868178      PMCID: PMC3880603          DOI: 10.1038/modpathol.2013.104

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  44 in total

1.  Adjusting batch effects in microarray expression data using empirical Bayes methods.

Authors:  W Evan Johnson; Cheng Li; Ariel Rabinovic
Journal:  Biostatistics       Date:  2006-04-21       Impact factor: 5.899

Review 2.  Classification of colorectal cancer based on correlation of clinical, morphological and molecular features.

Authors:  J R Jass
Journal:  Histopathology       Date:  2007-01       Impact factor: 5.087

3.  Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer.

Authors:  Wade S Samowitz; Hans Albertsen; Carol Sweeney; Jennifer Herrick; Bette J Caan; Kristin E Anderson; Roger K Wolff; Martha L Slattery
Journal:  J Natl Cancer Inst       Date:  2006-12-06       Impact factor: 13.506

4.  The oncogenic potential of deregulated homeobox genes.

Authors:  C C Maulbecker; P Gruss
Journal:  Cell Growth Differ       Date:  1993-05

5.  Expression of homeobox-containing genes in primary and metastatic colorectal cancer.

Authors:  G De Vita; P Barba; N Odartchenko; J C Givel; G Freschi; G Bucciarelli; M C Magli; E Boncinelli; C Cillo
Journal:  Eur J Cancer       Date:  1993       Impact factor: 9.162

6.  HOX gene expression in normal and neoplastic human kidney.

Authors:  C Cillo; P Barba; G Freschi; G Bucciarelli; M C Magli; E Boncinelli
Journal:  Int J Cancer       Date:  1992-07-30       Impact factor: 7.396

7.  Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample.

Authors:  Shuji Ogino; Takako Kawasaki; Gregory J Kirkner; Peter Kraft; Massimo Loda; Charles S Fuchs
Journal:  J Mol Diagn       Date:  2007-07       Impact factor: 5.568

8.  Expression of HOX homeogenes in human neuroblastoma cell culture lines.

Authors:  F A Peverali; M D'Esposito; D Acampora; G Bunone; M Negri; A Faiella; A Stornaiuolo; M Pannese; E Migliaccio; A Simeone
Journal:  Differentiation       Date:  1990-10       Impact factor: 3.880

9.  Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a 'fusion' pathway to colorectal cancer.

Authors:  J R Jass; K Baker; I Zlobec; T Higuchi; M Barker; D Buchanan; J Young
Journal:  Histopathology       Date:  2006-08       Impact factor: 5.087

10.  Capturing heterogeneity in gene expression studies by surrogate variable analysis.

Authors:  Jeffrey T Leek; John D Storey
Journal:  PLoS Genet       Date:  2007-08-01       Impact factor: 5.917

View more
  20 in total

1.  Comparison of biomarker expression between proximal and distal colorectal adenomas: The Tennessee-Indiana Adenoma Recurrence Study.

Authors:  Timothy Su; M Kay Washington; Reid M Ness; Douglas K Rex; Walter E Smalley; Thomas M Ulbright; Qiuyin Cai; Wei Zheng; Martha J Shrubsole
Journal:  Mol Carcinog       Date:  2016-08-11       Impact factor: 4.784

2.  Expression changes of cell-cell adhesion-related genes in colorectal tumors.

Authors:  Mateusz Bujko; Paulina Kober; Michal Mikula; Marcin Ligaj; Jerzy Ostrowski; Janusz Aleksander Siedlecki
Journal:  Oncol Lett       Date:  2015-04-08       Impact factor: 2.967

Review 3.  Different treatment strategies and molecular features between right-sided and left-sided colon cancers.

Authors:  Hong Shen; Jiao Yang; Qing Huang; Meng-Jie Jiang; Yi-Nuo Tan; Jian-Fei Fu; Li-Zhen Zhu; Xue-Feng Fang; Ying Yuan
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

4.  Tumor suppressors miR-143 and miR-145 and predicted target proteins API5, ERK5, K-RAS, and IRS-1 are differentially expressed in proximal and distal colon.

Authors:  Joel Pekow; Katherine Meckel; Urszula Dougherty; Fatma Butun; Reba Mustafi; John Lim; Charis Crofton; Xindi Chen; Loren Joseph; Marc Bissonnette
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-12-04       Impact factor: 4.052

Review 5.  Progress and opportunities in molecular pathological epidemiology of colorectal premalignant lesions.

Authors:  Paul Lochhead; Andrew T Chan; Edward Giovannucci; Charles S Fuchs; Kana Wu; Reiko Nishihara; Michael O'Brien; Shuji Ogino
Journal:  Am J Gastroenterol       Date:  2014-06-17       Impact factor: 10.864

6.  Association between adenoma location and risk of recurrence.

Authors:  Heiko Pohl; Douglas J Robertson; Leila A Mott; Dennis J Ahnen; Carol A Burke; Elizabeth L Barry; Robert S Bresalier; Jane C Figueiredo; Aasma Shaukat; Robert S Sandler; John A Baron
Journal:  Gastrointest Endosc       Date:  2016-03-11       Impact factor: 9.427

7.  Aberrant expression of annexin A10 is closely related to gastric phenotype in serrated pathway to colorectal carcinoma.

Authors:  Jia-Huei Tsai; Yu-Lin Lin; Yi-Chen Cheng; Chien-Chuan Chen; Liang-In Lin; Li-Hui Tseng; Mei-Ling Cheng; Jau-Yu Liau; Yung-Ming Jeng
Journal:  Mod Pathol       Date:  2014-08-01       Impact factor: 7.842

8.  Associations between circulating 1,25(OH)₂D concentration and odds of metachronous colorectal adenoma.

Authors:  Elizabeth A Hibler; Christine L Sardo Molmenti; Peter Lance; Peter W Jurutka; Elizabeth T Jacobs
Journal:  Cancer Causes Control       Date:  2014-04-16       Impact factor: 2.506

9.  Epigenetics and Colorectal Neoplasia: the Evidence for Physical Activity and Sedentary Behavior.

Authors:  Elizabeth Hibler
Journal:  Curr Colorectal Cancer Rep       Date:  2015-09-19

10.  Genome-wide DNA methylation analysis of colorectal adenomas with and without recurrence reveals an association between cytosine-phosphate-guanine methylation and histological subtypes.

Authors:  David Fiedler; Daniela Hirsch; Nady El Hajj; Howard H Yang; Yue Hu; Carsten Sticht; Indrajit Nanda; Sebastian Belle; Josef Rueschoff; Maxwell P Lee; Thomas Ried; Thomas Haaf; Timo Gaiser
Journal:  Genes Chromosomes Cancer       Date:  2019-08-10       Impact factor: 4.263

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.